Faisal Ghiath Sukhtian, Director at Outlook Therapeutics, bought OTLK on Jul 29, 2026

Data as of Oct 16

▲ BUY$100K95,398 shares at $1.05Faisal Ghiath Sukhtian DirectorOTLK Outlook Therapeutics, Inc.

Watch OTLK

Traded: Jul 29, 2026
Disclosed: Jul 29, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

OTLKSimilar stocks (XLV — its sector index fund), rebased to OTLK's price on the disclosure day

OTLK since disclosure

−51.2%

Similar stocks (XLV) since disclosure

+6.3%

XLV — its sector index fund

Change in closing price from Jul 29, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on OTLK →